Perskindol Active Patch Israel - hebraico - Ministry of Health

perskindol active patch

מדיטרנד שיווק (2004) בע"מ - כלל האוכלוסיה - מדבקה להקלה בכאבי שרירים

Perskindol Active Classic Gel Israel - hebraico - Ministry of Health

perskindol active classic gel

מדיטרנד שיווק (2004) בע"מ - כלל האוכלוסיה - ג'ל להקלה והרגעת כאבים כדוגמת כאבי שרירים וכאבים לאחר טראומה קלה

Perskindol Active Classic Spray Israel - hebraico - Ministry of Health

perskindol active classic spray

מדיטרנד שיווק (2004) בע"מ - כלל האוכלוסיה - תרסיס להקלה על כאבים מפציעות ספורט

Implants and Instruments for use in conjuction with active medical products for oral and extra oral implantology and for restora Israel - hebraico - Ministry of Health

implants and instruments for use in conjuction with active medical products for oral and extra oral implantology and for restora

דנטאוריינט פוס בע"מ - רופא שיניים - שתלים ואביזרים דנטליים המשמשים ברפואת שיניים

טרקליר 62.5 מג Israel - hebraico - Ministry of Health

טרקליר 62.5 מג

j-c health care ltd - bosentan - טבליות מצופות פילם - bosentan 62.5 mg - bosentan - bosentan - treatment of pulmonary arterial hypertension (pah) in patients of who functional class ii-iv.reduction in the number of new digital ulcers in patients with systemic sclerosis with active digital ulcer disease

טרקליר 125 מג Israel - hebraico - Ministry of Health

טרקליר 125 מג

j-c health care ltd - bosentan - טבליות מצופות פילם - bosentan 125 mg - bosentan - bosentan - treatment of pulmonary arterial hypertension (pah) in patients of who functional class ii-iv.reduction in the number of new digital ulcers in patients with systemic sclerosis with active digital ulcer disease

פלאג'יל 250 מג טבליות Israel - hebraico - Ministry of Health

פלאג'יל 250 מג טבליות

sanofi israel ltd - metronidazole - טבליות מצופות פילם - metronidazole 250 mg - metronidazole - metronidazole - trichomonias, acute intestinal amebiasis. infections due to anaerobic bacteria.

פלומיסט קואדריוואלנט Israel - hebraico - Ministry of Health

פלומיסט קואדריוואלנט

astrazeneca (israel) ltd - a/darwin/9/2021 (h3n2)-like virus; a/victoria/4897/2022 (h1n1)pdm09-like virus; b/austria/1359417/2021 (b/victoria lineage)-like virus; b/phuket/3073/2013 (b/yamagata lineage)-like virus - ספריי לאף - b/phuket/3073/2013 (b/yamagata lineage)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; a/darwin/9/2021 (h3n2)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; b/austria/1359417/2021 (b/victoria lineage)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; a/victoria/4897/2022 (h1n1)pdm09-like virus 7 ±0.5 log10 ffu^a / 0.2 ml - influenza, inactivated, split virus or surface antigen - influenza, purified antigen - flumist quadrivalent is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza a subtype viruses ad type b viruses contained in the vaccine. flumist quadrivalent is approved for use in persons 2 through 49 years of age.

אורנסיה 250 מג Israel - hebraico - Ministry of Health

אורנסיה 250 מג

bristol, myers squibb (israel) limited, israel - abatacept - אבקה להכנת תמיסה מרוכזת לעירוי - abatacept 250 mg - abatacept - abatacept - orencia in combination with methotrexate is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who responded inadequately to previous therapy with one or more disease modifying anti rheumatic drugs (dmards) including methotrexate (mtx) or a tnf-alpha inhibitor.a reduction in the progression of joint damage and improvement of physical function have been demonstrated during combination treatment with abatacept and methotrexate.polyarticular juvenile idiopathic arthritis:orencia in combination with methotrexate is indicated for the treatment of moderate to severe active polyarticular juvenile idiopathic arthritis (jia) in paediatric patients 6 years of age and older who have had an insufficient response to other dmards including at least one tnf inhibitor. orencia has not been studied in children under 6 years old.

אורנסיה 125 מג תת - עורי Israel - hebraico - Ministry of Health

אורנסיה 125 מג תת - עורי

bristol, myers squibb (israel) limited, israel - abatacept - תמיסה להזרקה - abatacept 125 mg/ml - abatacept - abatacept - orencia is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis. orencia may be used as monotherapy or concomitantly with disease-modifying antirheumatic drugs (dmards) other than tumor necrosis factor (tnf) antagonists.